Your browser doesn't support javascript.
loading
A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma.
Reiss, Kim A; Wattenberg, Max M; Damjanov, Nevena; Prechtel Dunphy, Elizabeth; Jacobs-Small, Mona; Lubas, M Judy; Robinson, James; Dicicco, Lisa; Garcia-Marcano, Luis; Giannone, Michael A; Karasic, Thomas B; Furth, Emma E; Carpenter, Erica L; Wojcieszynski, Andrzej P; Vonderheide, Robert H; Beatty, Gregory L; Ben-Josef, Edgar.
Afiliación
  • Reiss KA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. kim.reissbinder@pennmedicine.upenn.edu gregory.beatty@pennmedicine.upenn.edu.
  • Wattenberg MM; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Damjanov N; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Prechtel Dunphy E; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Jacobs-Small M; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Lubas MJ; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Robinson J; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Dicicco L; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Garcia-Marcano L; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Giannone MA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Karasic TB; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Furth EE; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Carpenter EL; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Wojcieszynski AP; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Vonderheide RH; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Beatty GL; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Ben-Josef E; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Mol Cancer Ther ; 20(2): 389-397, 2021 02.
Article en En | MEDLINE | ID: mdl-33268571
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Quinolinas / Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Aged / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Quinolinas / Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Aged / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article